GILD - GILEAD SCIENCES, INC.
100.02
0.110 0.110%
Share volume: 149,537
Last Updated: Wed 05 Feb 2025 06:28:54 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.33%
PREVIOUS CLOSE
CHG
CHG%
$99.91
0.11
0.11%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-03 | 2023-08-04 | 2023-11-07 | 2024-02-23 | 2024-05-08 | 2024-05-08 | 2024-08-08 | 2024-11-12 | |
| Total revenue | 6.352 B | 6.599 B | 7.050 B | 7.115 B | 6.686 B | 6.686 B | 6.954 B | 7.545 B | |
| Cost of revenue | 1.401 B | 1.442 B | 1.565 B | 2.090 B | 1.552 B | 1.552 B | 1.544 B | 1.574 B | |
| Gross profit | 4.951 B | 5.157 B | 5.485 B | 5.025 B | 5.134 B | 5.134 B | 5.410 B | 5.971 B | |
| 4.16% | 6.36% | -8.39% | 2.17% | 0.00% | 5.38% | 10.37% | |||
| Operating expenses | 2.766 B | 3.256 B | 2.772 B | 3.014 B | 7.026 B | 2.895 B | 2.766 B | 3.333 B | |
| Selling general and admin | 1.319 B | 1.849 B | 1.315 B | 1.607 B | 1.375 B | 1.375 B | 1.377 B | 1.433 B | |
| Research and development | 1.447 B | 1.407 B | 1.457 B | 1.407 B | 5.651 B | 1.520 B | 1.389 B | 1.900 B | |
| Total expenses | 4.167 B | 4.698 B | 4.337 B | 5.104 B | 9.456 B | 4.447 B | 2.766 B | 5.083 B | |
| 12.74% | -7.68% | 17.69% | 85.27% | -52.97% | -37.80% | 83.77% | |||
| Operating income | 2.185 B | 1.901 B | 2.713 B | 2.011 B | -4.322 B | 2.239 B | 2.644 B | 888.000 M | |
| Ebit | 2.185 B | 1.901 B | 2.713 B | 2.011 B | -4.231 B | 2.239 B | 2.289 B | 1.194 B | |
| Pretax income | 1.300 B | 1.587 B | 2.318 B | 1.654 B | -4.486 B | -4.485 B | 2.053 B | 956.000 M | |
| 22.08% | 46.06% | -28.65% | -371.22% | -0.02% | -145.77% | -53.43% | |||
| Income tax | 316.000 M | 549.000 M | 146.000 M | 236.000 M | -315.000 M | -315.000 M | 438.000 M | -297.000 M | |
| Net income basic | 1.010 B | 1.045 B | 2.180 B | 1.429 B | 0.000 | -4.170 B | 0.000 | 0.000 | |
| 3.47% | 108.61% | -34.45% | -100.00% | 100.00% | |||||
| Net income | 1.010 B | 1.045 B | 2.180 B | 1.429 B | -4.170 B | -4.170 B | 1.614 B | 1.253 B | |
| 3.47% | 108.61% | -34.45% | -391.81% | 0.00% | 138.71% | -22.37% |